DK0789583T3 - Fremgangsmåder og kits som anvender makrofagstimulerende protein - Google Patents

Fremgangsmåder og kits som anvender makrofagstimulerende protein

Info

Publication number
DK0789583T3
DK0789583T3 DK95937641T DK95937641T DK0789583T3 DK 0789583 T3 DK0789583 T3 DK 0789583T3 DK 95937641 T DK95937641 T DK 95937641T DK 95937641 T DK95937641 T DK 95937641T DK 0789583 T3 DK0789583 T3 DK 0789583T3
Authority
DK
Denmark
Prior art keywords
methods
msp
kits
stimulating protein
macrophage stimulating
Prior art date
Application number
DK95937641T
Other languages
English (en)
Inventor
Paul J Godowski
Hava Karsenty Avraham
Original Assignee
Genentech Inc
Beth Israel Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc, Beth Israel Hospital filed Critical Genentech Inc
Application granted granted Critical
Publication of DK0789583T3 publication Critical patent/DK0789583T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
DK95937641T 1994-11-03 1995-10-25 Fremgangsmåder og kits som anvender makrofagstimulerende protein DK0789583T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/334,177 US5696086A (en) 1994-11-03 1994-11-03 Methods and kits using macrophage stimulating protein
PCT/US1995/013830 WO1996014082A1 (en) 1994-11-03 1995-10-25 Methods and kits using macrophage stimulating protein

Publications (1)

Publication Number Publication Date
DK0789583T3 true DK0789583T3 (da) 2003-04-07

Family

ID=23305958

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95937641T DK0789583T3 (da) 1994-11-03 1995-10-25 Fremgangsmåder og kits som anvender makrofagstimulerende protein

Country Status (8)

Country Link
US (1) US5696086A (da)
EP (1) EP0789583B1 (da)
JP (1) JP3769691B2 (da)
AT (1) ATE229813T1 (da)
CA (1) CA2203528C (da)
DE (1) DE69529229T2 (da)
DK (1) DK0789583T3 (da)
WO (1) WO1996014082A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948892A (en) 1996-12-16 1999-09-07 Amgen Inc. Analogs of macrophage stimulating protein
IT1292017B1 (it) * 1997-05-28 1999-01-25 Dompe Spa Composizioni farmaceutiche contenenti la proteina stimolante i macrofagi per il trattamento di patologie del sistema nervoso
US6979442B1 (en) 1998-08-17 2005-12-27 Pfizer Inc. Stabilized protein compositions
US7235523B2 (en) * 2001-04-13 2007-06-26 Children's Hospital Medical Center Methods for the treatment of hepatic disorders
RU2015125642A (ru) * 2012-11-30 2017-01-11 Дженентек, Инк. Композиции ron и способы их применения

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
IE81149B1 (en) * 1987-02-12 2000-05-03 Genentech Inc Methods and deoxyribonucleic acid for the preparation of tissue factor protein
IL92937A0 (en) * 1989-01-31 1990-09-17 Us Health Human derived monocyte attracting protein,pharmaceutical compositions comprising it and dna encoding it
US5362716A (en) * 1989-12-27 1994-11-08 The United States Of America As Represented By The Department Of Health And Human Services Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines
US5219991A (en) * 1990-09-21 1993-06-15 The United States Of America As Represented By The Department Of Health And Human Services Macrophage stimulating protein
US5227158A (en) * 1991-06-10 1993-07-13 Genentech, Inc. Method of stimulating hepatocyte proliferation by administration of hepatocyte growth factor and gamma-interferon
US5316921A (en) * 1992-05-18 1994-05-31 Genentech, Inc. Single-chain hepatocyte growth factor variants
US5328837A (en) * 1992-05-18 1994-07-12 Genentech, Inc. Hepatocyte growth factor protease domain variants
US5352680A (en) * 1992-07-15 1994-10-04 Regents Of The University Of Minnesota Delta opioid receptor antagonists to block opioid agonist tolerance and dependence
IL107366A (en) * 1992-10-23 2003-03-12 Chugai Pharmaceutical Co Ltd Genes coding for megakaryocyte potentiator
JP3682984B2 (ja) * 1993-10-06 2005-08-17 テルモ株式会社 巨核球増加剤および血小板増加剤
US5547931A (en) * 1994-02-23 1996-08-20 Immtech International Inc. Methods of stimulatory thrombocytopoiesis using modified C-reactive protein

Also Published As

Publication number Publication date
CA2203528C (en) 2010-04-13
WO1996014082A1 (en) 1996-05-17
CA2203528A1 (en) 1996-05-17
MX9703134A (es) 1998-10-31
EP0789583A1 (en) 1997-08-20
EP0789583B1 (en) 2002-12-18
JPH10509446A (ja) 1998-09-14
DE69529229D1 (de) 2003-01-30
ATE229813T1 (de) 2003-01-15
JP3769691B2 (ja) 2006-04-26
US5696086A (en) 1997-12-09
DE69529229T2 (de) 2003-09-11

Similar Documents

Publication Publication Date Title
HK1014496A1 (en) Methods and compositions for the specific coagulation of tumoral vasculature
ATE185602T1 (de) Verändertes menschliches il-6
ZA975851B (en) Hepatocyte grown factor receptor agonists and uses thereof
GR3007096T3 (da)
MX9700538A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares.
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
IL159527A0 (en) Human dr4 antibodies and uses thereof
GR3006073T3 (da)
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
DE58902712D1 (de) N-acetylglucosamin-zubereitungen zur buccalen anwendung.
ATE35416T1 (de) Derivate des glycerophosphocholins und glycerophosphoethanolamins, ihre herstellung und verwendung.
DE69420251D1 (de) Löslicher Interferon-Rezeptor, seine Herstellung und Anwendung
DK0789583T3 (da) Fremgangsmåder og kits som anvender makrofagstimulerende protein
DK0465581T3 (da) Erythromycinderivater
FI916118A0 (fi) 2-aryl-5-(trifluormetyl)-2-pyrrolin- foereningar och foerfarande foer framstaellning av insekticida 2-aryl-1-(alkoximetyl)-4-halogen-5-(trifluormetyl)pyrroler.
FI922428A0 (fi) Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
ES2061566T3 (es) Anticuerpos monoclonales contra la proteina e7 del papilomavirus humano tipo 16, procedimiento para su preparacion, asi como su empleo.
IL131478A0 (en) Methods for treatment of scar tissue
GR3005231T3 (da)
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
MX9803272A (es) N-oxido de lubelozol.
GB9723824D0 (en) Cytostatic agents
IT8819879A0 (it) Composizioni farmaceutiche atte all'impiego nella terapia dell'ipotensione arteriosa.